(Seoul = Yonhap News) Reporter Kim Ye-na = A new coronavirus infection (Corona 19) vaccine is expected to be introduced in Korea as early as early next month.
At a regular briefing on the 23rd, Ko Jae-young, head of the crisis communication team at the Central Defense Countermeasures Headquarters (Bang Dae-bon), said, “A briefing on the implementation of the Corona 19 (vaccine) vaccination will be held on Thursday the 28th.”
The government has prepared the’Vaccination Enforcement Plan’, which specifically set the targets for vaccination and methods of vaccination through the’Corona 19 Vaccination Response Promotion Team’, led by the KCDC.
In summary, the vaccination plan is expected to include details on recommended targets for preferential vaccination, such as who will receive the corona 19 vaccine sequentially introduced from the beginning of next month, and where to receive it.
In addition, it is expected to contain information on how to manage if an adverse reaction occurs after vaccination.
The government has signed vaccine purchase contracts with individual pharmaceutical companies such as’COVAX facility’, an international project for joint vaccine purchase and distribution, and AstraZeneca, Janssen, Pfizer, and Modena. Secured.
In addition, it has almost completed a contract with Nova Bax to bring in an additional 20 million people.
Among them, Kobax’s initial supply of 50,000 people is expected to be the first to enter Korea in early February. Pfizer’s products are being actively considered for vaccines to be received from COVAX.
The government is speeding up the preparation work by designating and operating 10,000 consigned medical institutions and 250 vaccination centers to ensure smooth vaccination.
– .
